Access
To read this story in full you will need to login or make a payment (see right).
Letter
Nature 441, 518-522 (25 May 2006) | doi:10.1038/nature04747; Received 6 October 2005; Accepted 20 March 2006; Published online 23 April 2006
Open Innovation Challenges
-
Single-cell Analysis Platform
This Challenge is looking for novel approaches to analyzing changes at a single-cell level. This is...
-
Optimizing Sub-cellular Localization Tags
The Seeker is looking for methods to optimize sub-cellular localization tags for protein expression....
nature jobs
Copy Editor
- Indegene Lifesystems Pvt. Ltd
- Bengaluru 560 071 India
System Engineer (Mechanical)
- Praj Matrix - Praj Industries Ltd
- Pune, Maharashtra Pune-411021 India
PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention
Jiwang Zhang1, Justin C. Grindley1, Tong Yin1, Sachintha Jayasinghe1, Xi C. He1, Jason T. Ross1, Jeffrey S. Haug1, Dawn Rupp1, Kimberly S. Porter-Westpfahl1, Leanne M. Wiedemann1,3, Hong Wu2 & Linheng Li1,3
- Stowers Institute for Medical Research, Kansas City, Missouri 64110, USA
- Department of Molecular and Medical Pharmacology, UCLA School of Medicine, Los Angeles, California 90095, USA
- Department of Pathology and Laboratory Medicine, Kansas University Medical Center, Kansas City, Kansas 66160, USA
Correspondence to: Linheng Li1,3 Correspondence and requests for materials should be addressed to L.L. (Email: lil@stowers-institute.org).
Abstract
Haematopoietic stem cells (HSCs) must achieve a balance between quiescence and activation that fulfils immediate demands for haematopoiesis without compromising long-term stem cell maintenance, yet little is known about the molecular events governing this balance1, 2, 3. Phosphatase and tensin homologue (PTEN) functions as a negative regulator of the phosphatidylinositol-3-OH kinase (PI(3)K)–Akt pathway, which has crucial roles in cell proliferation, survival, differentiation and migration4, 5. Here we show that inactivation of PTEN in bone marrow HSCs causes their short-term expansion, but long-term decline, primarily owing to an enhanced level of HSC activation. PTEN-deficient HSCs engraft normally in recipient mice, but have an impaired ability to sustain haematopoietic reconstitution, reflecting the dysregulation of their cell cycle and decreased retention in the bone marrow niche. Mice with PTEN-mutant bone marrow also have an increased representation of myeloid and T-lymphoid lineages and develop myeloproliferative disorder (MPD)6. Notably, the cell populations that expand in PTEN mutants match those that become dominant in the acute myeloid/lymphoid leukaemia that develops in the later stages of MPD. Thus, PTEN has essential roles in restricting the activation of HSCs, in lineage fate determination, and in the prevention of leukaemogenesis.
- Stowers Institute for Medical Research, Kansas City, Missouri 64110, USA
- Department of Molecular and Medical Pharmacology, UCLA School of Medicine, Los Angeles, California 90095, USA
- Department of Pathology and Laboratory Medicine, Kansas University Medical Center, Kansas City, Kansas 66160, USA
Correspondence to: Linheng Li1,3 Correspondence and requests for materials should be addressed to L.L. (Email: lil@stowers-institute.org).
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Stressed marrow: FoxOs stem tumour growthNature Cell Biology News and Views (01 Mar 2007)
DNA methylation is a guardian of stem cell self-renewal and multipotencyNature Genetics News and Views (01 Nov 2009)
RESEARCH
Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cellsNature Article (25 May 2006)
Transcription factor Gfi1 regulates self-renewal and engraftment of hematopoietic stem cellsThe EMBO Journal Article (13 Oct 2004)
See all 26 matches for Research
